Radiomics Based on Artificial Intelligence in Liver Diseases: Where We Are?

Overview

Journal Gastroenterol Rep (Oxf)

Specialty Gastroenterology

Date 2020 Apr 14

PMID 32280468

Citations 21

Authors

Wenmo Hu

Huayu Yang

Haifeng Xu

Yilei Mao

Affiliations

Soon will be listed here.

Abstract

Radiomics uses computers to extract a large amount of information from different types of images, form various quantifiable features, and select relevant features using artificial-intelligence algorithms to build models, in order to predict the outcomes of clinical problems (such as diagnosis, treatment, prognosis, etc.). The study of liver diseases by radiomics will contribute to early diagnosis and treatment of liver diseases and improve survival and cure rates of liver diseases. This field is currently in the ascendant and may have great development in the future. Therefore, we summarize the progress of current research in this article and then point out the related deficiencies and the direction of future research.

Citing Articles

Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?.

Romeo M, Dallio M, Napolitano C, Basile C, Di Nardo F, Vaia P Diagnostics (Basel). 2025; 15(3).

PMID: 39941182 PMC: 11817573. DOI: 10.3390/diagnostics15030252.

The role of artificial intelligence and image processing in the diagnosis, treatment, and prognosis of liver cancer: a narrative-review.

Dimopoulos P, Mulita A, Antzoulas A, Bodard S, Leivaditis V, Akrida I Prz Gastroenterol. 2025; 19(3):221-230.

PMID: 39802971 PMC: 11718495. DOI: 10.5114/pg.2024.143147.

Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics.

Xia F, Wei W, Wang J, Duan Y, Wang K, Zhang C BMC Med Imaging. 2024; 24(1):221.

PMID: 39164667 PMC: 11334577. DOI: 10.1186/s12880-024-01398-y.

Comparing Texture Analysis of Apparent Diffusion Coefficient MRI in Hepatocellular Adenoma and Hepatocellular Carcinoma.

Abdullah A, Amanpour-Gharaei B, Toosi M, Delazar S, Saligheh Rad H, Arian A Cureus. 2024; 16(1):e51443.

PMID: 38298321 PMC: 10829059. DOI: 10.7759/cureus.51443.

Application and prospects of AI-based radiomics in ultrasound diagnosis.

Zhang H, Meng Z, Ru J, Meng Y, Wang K Vis Comput Ind Biomed Art. 2023; 6(1):20.

PMID: 37828411 PMC: 10570254. DOI: 10.1186/s42492-023-00147-2.

References

Yoneda M, Imajo K, Nakajima A . Will the magnetic resonance imaging proton density fat fraction replace liver biopsy as the gold standard for detecting steatosis?. Hepatobiliary Surg Nutr. 2018; 7(4):292-293. PMC: 6131261. DOI: 10.21037/hbsn.2018.04.02. View

Canellas R, Mehrkhani F, Patino M, Kambadakone A, Sahani D . Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units). AJR Am J Roentgenol. 2016; 207(5):W81-W87. DOI: 10.2214/AJR.15.15928. View

Aherne E, Pak L, Goldman D, Gonen M, Jarnagin W, Simpson A . Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?. Abdom Radiol (NY). 2018; 43(10):2665-2672. PMC: 6113129. DOI: 10.1007/s00261-018-1505-4. View

Margonis G, Buettner S, Andreatos N, Sasaki K, IJzermans J, van Vugt J . Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases. Ann Surg. 2017; 266(4):641-649. DOI: 10.1097/SLA.0000000000002367. View

Banerjee S, Wang D, Kim H, Sirlin C, Chan M, Korn R . A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology. 2015; 62(3):792-800. PMC: 4654334. DOI: 10.1002/hep.27877. View

Renzulli M, Brocchi S, Cucchetti A, Mazzotti F, Mosconi C, Sportoletti C . Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma?. Radiology. 2015; 279(2):432-42. DOI: 10.1148/radiol.2015150998. View

Raman S, Schroeder J, Huang P, Chen Y, Coquia S, Kawamoto S . Preliminary data using computed tomography texture analysis for the classification of hypervascular liver lesions: generation of a predictive model on the basis of quantitative spatial frequency measurements--a work in progress. J Comput Assist Tomogr. 2015; 39(3):383-95. DOI: 10.1097/RCT.0000000000000217. View

Cozzi L, Dinapoli N, Fogliata A, Hsu W, Reggiori G, Lobefalo F . Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. BMC Cancer. 2017; 17(1):829. PMC: 5718116. DOI: 10.1186/s12885-017-3847-7. View

Poon R, Fan S, Ng I, Lo C, Liu C, Wong J . Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000; 89(3):500-7. View

10.

Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S . Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2014; 261(5):947-55. DOI: 10.1097/SLA.0000000000000710. View

11.

Daginawala N, Li B, Buch K, Yu H, Tischler B, Qureshi M . Using texture analyses of contrast enhanced CT to assess hepatic fibrosis. Eur J Radiol. 2016; 85(3):511-7. DOI: 10.1016/j.ejrad.2015.12.009. View

12.

Younossi Z, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H . Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011; 9(6):524-530.e1. DOI: 10.1016/j.cgh.2011.03.020. View

13.

Zhou W, Zhang L, Wang K, Chen S, Wang G, Liu Z . Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images. J Magn Reson Imaging. 2016; 45(5):1476-1484. DOI: 10.1002/jmri.25454. View

14.

Li M, Fu S, Zhu Y, Liu Z, Chen S, Lu L . Computed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinoma. Oncotarget. 2016; 7(11):13248-59. PMC: 4914356. DOI: 10.18632/oncotarget.7467. View

15.

Lubner M, Malecki K, Kloke J, Ganeshan B, Pickhardt P . Texture analysis of the liver at MDCT for assessing hepatic fibrosis. Abdom Radiol (NY). 2017; 42(8):2069-2078. DOI: 10.1007/s00261-017-1096-5. View

16.

Pinker K, Shitano F, Sala E, Do R, Young R, Wibmer A . Background, current role, and potential applications of radiogenomics. J Magn Reson Imaging. 2017; 47(3):604-620. PMC: 5916793. DOI: 10.1002/jmri.25870. View

17.

Lim K, Chow P, Allen J, Chia G, Lim M, Cheow P . Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg. 2011; 254(1):108-13. DOI: 10.1097/SLA.0b013e31821ad884. View

18.

Kassner A, Thornhill R . Texture analysis: a review of neurologic MR imaging applications. AJNR Am J Neuroradiol. 2010; 31(5):809-16. PMC: 7964174. DOI: 10.3174/ajnr.A2061. View

19.

Oliveira C, Stefano J, Carrilho F . Clinical patterns of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD): a multicenter prospective study. Hepatobiliary Surg Nutr. 2017; 6(5):350-352. PMC: 5673767. DOI: 10.21037/hbsn.2017.06.06. View

20.

Torres D, Williams C, Harrison S . Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2012; 10(8):837-58. DOI: 10.1016/j.cgh.2012.03.011. View